EUVIMEDEUVIMED entdecken
Open Access

Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy

Li Chen, Zhijie Deng, Yan Xiong, Jing Liu, Daoyuan Huang, Jingchao Wang, Yong Chen, Hiroyuki Inuzuka, Ling Xie, Xian Chen, Jian Jin iD, Wenyi Wei iD

Journal of the American Chemical Society · 20.08.2025 · 147 (33) · 29875-29883

DOI: 10.1021/jacs.5c06306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 06.08.2025. Verfasst von Li Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Deubiquitinating Enzymes, Neoplasms, Von Hippel-Lindau Tumor Suppressor Protein. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesDeubiquitinating EnzymesNeoplasmsVon Hippel-Lindau Tumor Suppressor ProteinAntineoplastic AgentsKelch-Like ECH-Associated Protein 1HumansProtein StabilityCell Line, Tumor

Substanzen

Ubiquitin-Protein LigasesDeubiquitinating EnzymesVon Hippel-Lindau Tumor Suppressor ProteinAntineoplastic AgentsVHL protein, humanKelch-Like ECH-Associated Protein 1OTUB1 protein, humanKEAP1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, U…
  • Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Jian Jin, Wenyi Wei

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • NIH Office of the Director
  • Icahn School of Medicine at Mount Sinai

Zitieren

APA

Chen, L., Deng, Z., Xiong, Y., Liu, J., Huang, D., Wang, J., Chen, Y., Inuzuka, H., Xie, L., Chen, X., Jin, J., & Wei, W. (2025). Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy. Journal of the American Chemical Society, 147(33), 29875-29883. https://doi.org/10.1021/jacs.5c06306

Vancouver

Chen L, Deng Z, Xiong Y, Liu J, Huang D, Wang J, et al. Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy. Journal of the American Chemical Society. 2025;147(33):29875-29883. doi:10.1021/jacs.5c06306

BibTeX
@article{Chen2025,
  author = {Chen, Li and Deng, Zhijie and Xiong, Yan and Liu, Jing and Huang, Daoyuan and Wang, Jingchao and Chen, Yong and Inuzuka, Hiroyuki and Xie, Ling and Chen, Xian and Jin, Jian and Wei, Wenyi},
  title = {Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  volume = {147},
  number = {33},
  pages = {29875--29883},
  doi = {10.1021/jacs.5c06306}
}
Kostenlos starten →